Metabolic Syndrome Model Definitions Predicting Type 2 Diabetes and Cardiovascular Disease
Open Access
- 17 January 2013
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (2) , 362-368
Abstract
OBJECTIVE Metabolic syndrome (MetS) is a cluster of abdominal obesity, hyperglycemia, hypertension, and dyslipidemia, which increases the risk for type 2 diabetes and cardiovascular diseases (CVDs). Some argue that MetS is not a single disorder because the traditional MetS features do not represent one entity, and they would like to exclude features from MetS. Others would like to add additional features in order to increase predictive ability of MetS. The aim of this study was to identify a MetS model that optimally predicts type 2 diabetes and CVD while still representing a single entity. RESEARCH DESIGN AND METHODS In a random sample (n = 1,928) of the EPIC-NL cohort and a subset of the EPIC-NL MORGEN study (n = 1,333), we tested the model fit of several one-factor MetS models using confirmatory factor analysis. We compared predictive ability for type 2 diabetes and CVD of these models within the EPIC-NL case-cohort study of 545 incident type 2 diabetic subjects, 1,312 incident CVD case subjects, and the random sample, using survival analyses and reclassification. RESULTS The standard model, representing the current MetS definition (EPIC-NL comparative fit index [CFI] = 0.95; MORGEN CFI = 0.98); the standard model excluding blood pressure (EPIC-NL CFI = 0.95; MORGEN CFI = 1.00); and the standard model extended with hsCRP (EPIC-NL CFI = 0.95) had an acceptable model fit. The model extended with hsCRP predicted type 2 diabetes (integral discrimination index [IDI]: 0.34) and CVD (IDI: 0.07) slightly better than did the standard model. CONCLUSIONS It seems valid to represent the traditional MetS features by a single entity. Extension of this entity with hsCRP slightly improves predictive ability for type 2 diabetes and CVD.Keywords
This publication has 36 references indexed in Scilit:
- Systemic inflammation and the metabolic syndrome among middle-aged community volunteersMetabolism, 2010
- Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular DiseaseDiabetes Care, 2010
- Validity of a Single-Factor Model Underlying the Metabolic Syndrome in ChildrenDiabetes Care, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Cohort Profile: The EPIC-NL studyInternational Journal of Epidemiology, 2009
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Use of confirmatory factor analysis for the identification of new components of the metabolic syndrome: The role of plasminogen activator inhibitor-1 and Haemoglobin A1cNutrition, Metabolism and Cardiovascular Diseases, 2008
- Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysisDiabetologia, 2006
- A Single Factor Underlies the Metabolic Syndrome: A confirmatory factor analysisDiabetes Care, 2006
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004